Combination Therapy Evaluation Method for Efficacy and Potency Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack effective ways to evaluate the therapeutic benefit of combination therapies, particularly in terms of efficacy and potency, making it difficult to determine when combination therapies provide improved reduction in disease burden or allow for lower doses to minimize adverse side effects.
Innovation Solution
The method involves separately analyzing the impact of combination therapy on efficacy and potency compared to the most efficacious single therapeutic agents, using equations to determine therapeutic effects and considering factors like safety, resistance, and drug interactions, and evaluating biological pathways and cell types impacted by the therapy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If combination therapy is used to treat medical disorders, then therapeutic efficacy is improved, but treatment complexity increases
Solution Approach 1:
The patent segments the evaluation of combination therapy into distinct components: evaluating efficacy impact separately from potency impact for each therapeutic agent. This segmentation allows complex combination therapy effects to be broken down into manageable, independently analyzable parts, resolving the contradiction by making the evaluation process structured and systematic rather than overwhelming.
Solution Approach 2:
The patent introduces a new dimensional framework for evaluating combination therapies by separately analyzing efficacy and potency impacts across multiple dosage combinations. This multi-dimensional evaluation approach transforms the complex assessment into a systematic grid analysis, allowing comprehensive evaluation without proportionally increasing complexity.
2Reliability
If higher doses of therapeutic agents are used to maximize efficacy, then disease burden reduction is improved, but adverse side effects increase
Solution Approach 1:
The patent systematically varies dosage parameters across multiple combinations of therapeutic agents to identify optimal dosing regimens. By changing dosage parameters and evaluating their impact on both efficacy and adverse effects, the method identifies parameter combinations that maximize therapeutic benefit while minimizing harm, directly resolving this contradiction.
Solution Approach 2:
The patent evaluates not only full therapeutic doses but also partial doses and sub-maximal combinations to identify the minimum effective dosing regimen. This approach allows identification of dosage levels that provide sufficient disease burden reduction without exceeding the threshold for excessive adverse side effects.
3Reliability
If multiple therapeutic agents are combined to target different aspects of disease, then therapeutic benefit is improved, but difficulty in evaluating therapeutic effect increases
Solution Approach 1:
The patent segments the evaluation into distinct analytical components: (1) evaluating the impact on efficacy provided by the combination relative to the most efficacious single agent, (2) evaluating the impact on potency of each agent when used in combination versus alone. This segmentation transforms the difficult task of evaluating multiple agents into systematic, separate assessments that can be independently performed and then integrated.
Solution Approach 2:
The patent introduces controlled experimental conditions and standardized evaluation metrics as intermediaries between the complex combination therapy and the assessment process. By using consistent dosing regimens, controlled study designs, and standardized measurement approaches, the method mediates the complexity of multi-agent evaluation into comparable, interpretable results.
Data Source
AI summary
The invention provides methods for evaluating the therapeutic benefit of a combination therapy useful for treating a medical disorder, such as cancer.